A Doctor-Led Diabetes Reversal Program
Type 2 Diabetes can be reversed. A structured six-month programme combining continuous glucose monitoring, personalised nutrition, and weekly medical support gives your body the conditions it needs to restore normal blood sugar control and reduce or eliminate medication.
Remission is defined internationally as an HbA1c below 6.5% sustained for at least three months without hypoglycaemic medication. It is achievable for many people with Type 2 Diabetes through a structured, medically supervised programme. The mechanisms are well understood.
Excess fat stored in and around the liver and pancreas directly impairs insulin production and insulin sensitivity. Reducing visceral fat removes the primary metabolic block and allows the pancreas to function more normally.
When cells become more responsive to insulin, blood sugar regulation improves significantly. Dietary change, physical activity, and weight loss each independently improve insulin sensitivity, and their combined effect is substantial.
In many patients, the insulin-producing beta cells of the pancreas are not permanently damaged but functionally suppressed by chronic metabolic stress. Removing that stress through structured lifestyle intervention allows beta cell function to partially or fully recover.
An important note on remission: Not everyone achieves full remission, and outcomes depend on the duration of diabetes, baseline HbA1c, degree of beta cell preservation, and adherence to the programme. Metabolic risk persists lifelong even after remission. Ongoing lifestyle adherence and six-monthly HbA1c monitoring are recommended for all patients who achieve remission.
The programme is open to adults across India through the online pathway and in person at our clinic. A physician assessment at enrolment confirms eligibility and identifies any conditions requiring special consideration.
Early intervention offers the best chance of achieving full remission. Starting the programme before long-term complications develop maximises the benefit of lifestyle medicine.
Those with longer-standing diabetes can achieve meaningful HbA1c reduction, medication reduction, and significant improvement in metabolic health, even if full remission is not the primary goal.
Intervening at the pre-diabetes stage can prevent the progression to Type 2 Diabetes entirely. The programme addresses the metabolic root causes before full diabetes develops.
Patients currently on oral hypoglycaemic agents or insulin who want to reduce or stop medications under medical supervision. Medication adjustment is managed safely by the physician throughout the programme.
The online pathway makes the full programme available anywhere in India. All consultations and dietary coaching are conducted remotely. The CGM is shipped directly to the patient.
South Asian populations develop metabolic dysfunction at lower BMI values than Western populations. The programme uses the South Asian BMI threshold of 23 as the eligibility cutoff.
This programme is not suitable for Type 1 Diabetes, LADA, advanced diabetic complications (end-stage renal disease, proliferative retinopathy), uncontrolled hypertension, active malignancy, or pregnancy. Patients on sulphonylureas or insulin undergo a specific pre-enrolment physician review to confirm safety before the CGM diet trial begins.
The programme runs for six months across two phases. Phase 1 is intensive and data-driven. Phase 2 consolidates the habits and metabolic improvements achieved in Phase 1 with ongoing professional support.
Phase 1 begins with a comprehensive enrolment assessment covering your full medical history, baseline blood tests, body composition analysis, physical fitness evaluation, and application of a continuous glucose monitor. The first two weeks are the most intensive period: a structured CGM diet trial during which the physician reviews your glucose data every working day and adjusts medication as clinically indicated, while the dietitian modifies your meal plan in real time based on your individual glycaemic response.
Following the CGM trial, a personalised diet and activity plan is finalised for Weeks 3 to 8. Fortnightly physician consultations and weekly dietitian sessions continue throughout Phase 1. Progress is tracked through DigiDiaCare, which captures glucose readings, diet, sleep, and activity daily.
Phase 2 shifts the focus from intensive reset to sustainable habit formation and long-term metabolic stability. Monthly physician consultations review your blood sugar trends, medication requirements, and exercise progress. Weekly dietitian sessions continue throughout all four months, addressing dietary adherence, evidence-based nutrition education, and any barriers to long-term sustainability.
Blood tests are repeated at Month 3 and Month 6. Body composition and grip strength are reassessed at both in-person visits for offline patients. The programme outcome guarantee is assessed at the Month 3 consultation. At Month 6, the physician issues a comprehensive end-of-programme report and a written maintenance plan covering ongoing monitoring and lifestyle targets.
No two people respond to food the same way. The CGM diet trial is a structured two-week period at the start of the programme during which you wear a continuous glucose monitor and follow a carefully designed meal plan. The physician and dietitian review your glucose data every working day and adjust your diet and medication in real time based on your individual response. By the end of the trial, you have a personalised diet plan built on your actual metabolic data, not a generic template. You can learn more about how CGM works here.
CGM is applied at enrolment. The dietitian sends a structured sample meal plan on Day 1 to trial specific food combinations.
You log all meals, sleep, and activity in DigiDiaCare daily. The team reviews your glucose graphs and meal logs every working day.
The physician adjusts diabetes medication as needed to prevent hypoglycaemia as your carbohydrate intake changes during the trial.
At the end of Week 2, the physician and dietitian jointly review the full two-week CGM data and finalise your personalised plan for Weeks 3 to 8.
Every element of the programme is integrated. The tools, tests, and support work together as a single clinical system.
CGM applied at enrolment. For online patients, the sensor is shipped by us. Learn about CGM.
Fat mass, lean mass, and visceral fat measured at enrolment, Month 3, and Month 6 for offline patients. Learn about body composition analysis.
HbA1c, fasting insulin, creatinine, CBC, lipids, liver function, thyroid, and urine microalbumin at baseline. HbA1c, creatinine, and CBC at Month 3 and Month 6.
Four fortnightly consultations in Phase 1 and four monthly consultations in Phase 2. All include CGM or glucose data review and medication assessment.
Eight weekly sessions in Phase 1 and sixteen in Phase 2, covering dietary adherence, meal planning, exercise guidance, and motivational support throughout.
Daily logging of glucose, diet, sleep, and activity. The physician and dietitian review your DigiDiaCare data at every consultation. Learn about DigiDiaCare.
Full age-appropriate fitness battery at enrolment for offline patients, including grip strength, cardiorespiratory fitness, and functional tests. View fitness assessment.
A private WhatsApp group with the physician, dietitian, and clinical assistant is created at enrolment for daily communication during the CGM trial and ongoing support.
A comprehensive written report at Month 6 documenting remission status where applicable, and a maintenance plan covering ongoing monitoring and lifestyle targets.
The programme is designed to be fully effective through both pathways. The clinical framework, support structure, and outcome targets are identical. The differences relate to in-person access to our equipment and facilities.
We are confident in the clinical effectiveness of this programme for patients who engage with it consistently. That confidence is backed by a formal guarantee.
Eligible patients who do not achieve the target HbA1c reduction by the Month 3 review receive an additional month of support at no charge. This includes a repeat two-week structured diet trial with daily dietitian guidance, four additional weekly dietitian sessions, and one additional physician consultation.
The target is a reduction of 1.0% or more from baseline HbA1c for patients with HbA1c above 7.0%, or 0.5% or more for patients with pre-diabetes or well-controlled diabetes at baseline.
The guarantee applies to patients who have engaged genuinely and consistently with the programme, including attending the required physician consultations and dietitian sessions, maintaining active DigiDiaCare logging, and completing the required blood tests at the scheduled timepoints. Adherence is assessed by the physician at the Month 3 consultation and documented in the patient record.
The programme is structured in two phases with separate fees, giving you the option to begin with Phase 1 and decide on Phase 2 after reviewing your progress. Phase 1 is clinically complete in its own right as a metabolic assessment and reset.
In-person at our clinic
Phase 1 payment is collected in full at enrolment. Phase 2 payment is confirmed at the Week 8 consultation before the Month 3 booking is released.
Available anywhere in India
Laboratory investigations for online patients are conducted at a local laboratory of your choice at Day 1, Month 3, and Month 6. Results are shared with the physician via the programme WhatsApp group.
From your first consultation to completing the programme, every step is clearly structured and guided by the clinical team.
The physician completes a full medical history, confirms eligibility, identifies any medications requiring adjustment, and orders the Day 1 baseline laboratory panel. For offline patients, the clinical team conducts the full physical fitness battery and applies the CGM on the same visit. The WhatsApp group is created and the dietitian sends the initial diet trial plan before you leave.
The most intensive two weeks of the programme. You follow a structured meal plan while wearing the CGM. The dietitian contacts you every working day to review your glucose graphs and meal logs. The physician reviews your CGM data daily and adjusts medication as needed. Your diet is modified progressively based on your real glucose response.
At the end of the CGM trial, the physician and dietitian jointly review your two weeks of data and finalise a personalised diet and activity plan for Weeks 3 to 8. Medications are confirmed. This plan is built on your individual metabolic response, not a generic template.
Fortnightly physician consultations and weekly dietitian sessions continue throughout Phase 1. Your DigiDiaCare data, home glucose readings, weight change, and medication response are reviewed at each consultation. At Week 8, your Phase 1 progress is summarised and the decision on Phase 2 is made.
Blood tests are repeated. For offline patients, body composition and grip strength are reassessed. The outcome guarantee eligibility is formally assessed and documented. Medications are reviewed in light of your metabolic progress. Phase 2 continues with monthly physician consultations and weekly dietitian sessions.
The final consultation includes a comprehensive review of your full six-month progress. Remission status is formally documented where applicable. A written maintenance plan covering ongoing monitoring frequency, lifestyle targets, and recommended six-monthly HbA1c checks is issued to you at this visit.
Enrol in Reboot Diabetes and begin a structured six-month programme designed to restore your metabolic health with the full support of a clinical team.